Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 30;16(6):813.
doi: 10.3390/ph16060813.

Extra-Gonadal and Non-Canonical Effects of FSH in Males

Affiliations
Review

Extra-Gonadal and Non-Canonical Effects of FSH in Males

Matteo Spaziani et al. Pharmaceuticals (Basel). .

Abstract

Recombinant follicle-stimulating hormone (FSH) is commonly used for the treatment of female infertility and is increasingly being used in males as well, as recommended by notable guidelines. FSH is composed of an α subunit, shared with other hormones, and a β subunit, which confers specificity of biological action by interacting with its surface receptor (FSHR), predominantly located in granulosa and Sertoli cells. However, FSHRs also exist in extra-gonadal tissues, indicating potential effects beyond male fertility. Emerging evidence suggests that FSH may have extra-gonadal effects, including on bone metabolism, where it appears to stimulate bone resorption by binding to specific receptors on osteoclasts. Additionally, higher FSH levels have been associated with worse metabolic and cardiovascular outcomes, suggesting a possible impact on the cardiovascular system. FSH has also been implicated in immune response modulation, as FSHRs are expressed on immune cells and may influence inflammatory response. Furthermore, there is growing interest in the role of FSH in prostate cancer progression. This paper aims to provide a comprehensive analysis of the literature on the extra-gonadal effects of FSH in men, with a focus on the often-conflicting results reported in this field. Despite the contradictory findings, the potential for future development in this area is substantial, and further research is needed to elucidate the mechanisms underlying these effects and their clinical implications.

Keywords: FSH; bone; cardiovascular system; extra-gonadal; immune system; infertility; metabolism; prostate cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Extragonadal effects of FSH. Established and potential FSH effects on organs and systems. Abbreviations: TNF (tumor necrosis factor), IL (interleukin), UCP (uncoupling protein), IFN (interferon), RANK (Receptor activator of nuclear factor κ B), RANKL (Receptor activator of nuclear factor kappa-Β ligand), FSH (follicle-stimulating hormone). Figures made under Creative Commons License by using the Adobe Stock platform.

References

    1. Spaziani M., Tarantino C., Tahani N., Gianfrilli D., Sbardella E., Lenzi A., Radicioni A.F. Hypothalamo-Pituitary axis and puberty. Mol. Cell. Endocrinol. 2021;520:111094. doi: 10.1016/j.mce.2020.111094. - DOI - PubMed
    1. Bhartiya D., Patel H. An overview of FSH-FSHR biology and explaining the existing conundrums. J. Ovarian Res. 2021;14:144. doi: 10.1186/s13048-021-00880-3. - DOI - PMC - PubMed
    1. Recchia K., Jorge A.S., Pessoa L.V.F., Botigelli R.C., Zugaib V.C., de Souza A.F., Martins D.D.S., Ambrosio C.E., Bressan F.F., Pieri N.C.G. Actions and Roles of FSH in Germinative Cells. Int. J. Mol. Sci. 2021;22:10110. doi: 10.3390/ijms221810110. - DOI - PMC - PubMed
    1. Simoni M., Gromoll J., Nieschlag E. The follicle-stimulating hormone receptor: Biochemistry, molecular biology, physiology, and pathophysiology. Endocr. Rev. 1997;18:739–773. - PubMed
    1. Bonfil D., Chuderland D., Kraus S., Shahbazian D., Friedberg I., Seger R., Naor Z. Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-stimulating hormone beta-subunit promoter. Endocrinology. 2004;145:2228–2244. doi: 10.1210/en.2003-1418. - DOI - PubMed

LinkOut - more resources